Zobrazeno 1 - 10
of 60
pro vyhledávání: '"E. S. KROPACHEVA"'
Publikováno v:
Атеротромбоз, Vol 13, Iss 1, Pp 46-57 (2023)
Introduction. Lengthening the period of direct oral anticoagulant (DOAC) withdrawal before intervention is not allowed. Chronic kidney disease (CKD), impaired liver function, extremely low or high body mass, chronic heart failure (CHF), and age > 90
Externí odkaz:
https://doaj.org/article/03e97d69c95149df81b09922849727b6
Autor:
E. S. Kropacheva, E. P. Panchenko
Publikováno v:
Атеротромбоз, Vol 13, Iss 1, Pp 36-45 (2023)
This review is devoted to the aspects of anticoagulant therapy in patients with atrial fibrillation in the light of the modern understanding of this type of arrhythmia as a polymorbid continuously developing syndrome. According to experts, the manage
Externí odkaz:
https://doaj.org/article/5d6ee33ff4f34e448ac0343d721b9875
Publikováno v:
Атеротромбоз, Vol 12, Iss 1, Pp 20-28 (2022)
Currently, direct oral anticoagulants (DOACs) should be preferred when prescribing anticoagulant therapy to atrial fibrillation patients because of their lower potential for interactions and risk of bleeding than warfarin. However, in the absence of
Externí odkaz:
https://doaj.org/article/71611dab20b84396b106049e7821be96
Publikováno v:
Атеротромбоз, Vol 0, Iss 1, Pp 68-88 (2021)
Introduction. Despite the large evidence base for the use of rivaroxaban, cohort studies are interesting because shows the possibility of anticoagulant therapy in patients with high thromboembolic and bleeding risk and a burden of comorbidity in prac
Externí odkaz:
https://doaj.org/article/7fc1d804582e418a9a7859e33ae304e9
Autor:
E. S. Kropacheva, E. P. Panchenko
Publikováno v:
Атеротромбоз, Vol 0, Iss 2, Pp 17-26 (2020)
This review focuses on some aspects of anticoagulant therapy in the updated clinical guidelines for atrial fibrillation of the European society of cardiology, published in 2020. Atrial fibrillation is a polymorbid continuously developing syndrome, an
Externí odkaz:
https://doaj.org/article/c3011425ffd14fefa34605409fc96694
Publikováno v:
Терапевтический архив, Vol 92, Iss 9, Pp 15-23 (2020)
Aim.To analyze the frequency of resumption of anticoagulant therapy (ACT) after major and clinically significant bleeding among AF patients who received oral anticoagulants and were observed in the Department of clinical problems of atherothrombosis
Externí odkaz:
https://doaj.org/article/7b614968abfd462aa40524e58bb1f955
Autor:
E. S. Kropacheva
Publikováno v:
Атеротромбоз, Vol 0, Iss 1, Pp 134-152 (2020)
This review systematizes the currently known data on intracardiac thrombosis. The main nosology leading to left atrial thrombosis is atrial fibrillation, with up to 90% of all trombi forming in the left atrial appendage. The optimal method to diagnos
Externí odkaz:
https://doaj.org/article/ad05ea20e2ba4a8aa8ca10bf3cfebca2
Publikováno v:
Российский кардиологический журнал, Vol 26, Iss 7 (2021)
Aim. To study the predictive value of growth differentiation factor 15 (GDF-15) in patients with atrial fibrillation (AF) after elective percutaneous coronary intervention (PCI).Material and methods. The study included 150 patients (men, 69,3%) with
Externí odkaz:
https://doaj.org/article/ba9a03d5455540a09be2d243a3e156c7
Autor:
M. G. Arakelyan, L. A. Bockeria, E. Yu. Vasilieva, S. P. Golitsyn, E. Z. Golukhova, M. V. Gorev, K. V. Davtyan, O. M. Drapkina, E. S. Kropacheva, E. A. Kuchinskaya, L. Yu. Lajovich, N. Yu. Mironov, I. E. Mishina, E. P. Panchenko, A. Sh. Revishvili, F. G. Rzayev, B. A. Tatarsky, M. D. Utsumueva, O. O. Shakhmatova, N. B. Shlevkov, A. V. Shpektor, D. A. Andreev, E. A. Artyukhina, O. L. Barbarash, A. S. Galyavich, D. V. Duplyakov, S. A. Zenin, D. S. Lebedev, E. N. Mikhailov, N. A. Novikova, S. V. Popov, A. G. Filatov, E. V. Shlyakhto, Yu. V. Shubik
Publikováno v:
Российский кардиологический журнал, Vol 26, Iss 7 (2021)
Russian Society of Cardiology (RSC).With the participation of Russian Scientific Society of Clinical Electrophysiology, Arrhythmology and Cardiac Pacing, Russian Association of Cardiovascular Surgeons.Approved by the Scientific and Practical Council
Externí odkaz:
https://doaj.org/article/bec19ff68992493eb9e972f8b2328631
Autor:
S. P. Golitsyn, E. P. Panchenko, E. S. Kropacheva, L. Yu. Layovich, E. B. Maikov, N. Yu. Mironov, O. O. Shakhmatova
Publikováno v:
Евразийский Кардиологический Журнал, Vol 0, Iss 4, Pp 4-85 (2019)
Externí odkaz:
https://doaj.org/article/84663bffe54142379621feb27776db95